Stryker Corporation (SYK)

Stryker Corporation (SYK $377.11)
- $377.11 P/E (TTM): 50.77X Cap: $146.55B
- View SYK Profile
- View Questions on SYK

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $274.40)
- $274.40 P/E (TTM): 22.58X Cap: $147.72B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $433.99)
- $433.99 P/E (TTM): 62.63X Cap: $161.19B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $217.61)
- $217.61 P/E (TTM): 104.47X Cap: $385.71B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $748.19)
- $748.19 P/E (TTM): 49.37X Cap: $708.12B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $377.11)
- $377.11 P/E (TTM): 50.77X Cap: $146.55B
- View SYK Profile
- View Questions on SYK
Novo Nordisk A/S (NVO $55.62)
- $55.62 P/E (TTM): 15.42X Cap: $363.68B
- View NVO Profile
- View Questions on NVO

Q: I sold a portion of my NVO holdings a while ago, and am not inclined to buy it back just now. What would you see as the best buy in the US healthcare sector these days; possibly as a compliment to NVO, but not necessarily?

Read Answer Asked by David on August 13, 2025

Stryker Corporation (SYK $377.11)
- $377.11 P/E (TTM): 50.77X Cap: $146.55B
- View SYK Profile
- View Questions on SYK

Q: Would you purchase this stock at it's current price for a five year hold?

Read Answer Asked by Brian on August 12, 2025

Amgen Inc. (AMGN $274.40)
- $274.40 P/E (TTM): 22.58X Cap: $147.72B
- View AMGN Profile
- View Questions on AMGN
Intuitive Surgical Inc. (ISRG $433.99)
- $433.99 P/E (TTM): 62.63X Cap: $161.19B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $217.61)
- $217.61 P/E (TTM): 104.47X Cap: $385.71B
- View ABBV Profile
- View Questions on ABBV
Stryker Corporation (SYK $377.11)
- $377.11 P/E (TTM): 50.77X Cap: $146.55B
- View SYK Profile
- View Questions on SYK
UnitedHealth Group Incorporated (DE) (UNH $347.89)
- $347.89 P/E (TTM): 14.76X Cap: $317.25B
- View UNH Profile
- View Questions on UNH
iShares U.S. Medical Devices ETF (IHI $60.34)
- $60.34 P/E (TTM): 28.37X Cap: $4.18B
- View IHI Profile
- View Questions on IHI

Q: I have been reviewing my health care holdings and I am disappointed in the whole sector. Their percentage of my holdings has dropped, and if I rebalance I should be adding another 50% to these holdings. I am unhappy with IHI and UNH, even ISRG is in the doldrums. Your thoughts on adding to the health care sector and these companies/ETFs at this time. Are there other companies much better suited that I am missing. I am tempted to remove the whole sector from my portfolio, as I am comfortable with risk.

Read Answer Asked by Gordon on August 14, 2025